510(k) K014233
K014233 is an FDA 510(k) premarket notification submitted by Trinity Biotech, Plc for the device "CAPTIAM SYPHILIS-G ASSAY". The FDA issued a decision of Substantially Equivalent on Jan 24, 2002. The device falls under product code LIP (Enzyme Linked Immunoabsorption Assay, Treponema Pallidum), a Class II device regulated under 21 CFR 866.3830. Trinity Biotech, Plc has 11 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 24, 2002
- Date Received
- Dec 26, 2001
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Linked Immunoabsorption Assay, Treponema Pallidum
- Device Class
- Class II
- Regulation Number
- 866.3830
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Trinity Biotech, Plc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.